San Francisco, CA, United States of America

Harris Goodman

This inventor holds 2 USPTO granted patents. Top assignee: Penederm, Inc.. Active years: 1997.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Harris Goodman. Retrieved from https://idiyas.com/inventor/harris-goodman

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 2

Forward Citations = 22(Granted Patents)


Company Filing History:


Years Active: 1997

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Harris Goodman in Dermatological Compositions

Introduction

Harris Goodman is an accomplished inventor based in San Francisco, CA. He has made significant contributions to the field of dermatology through his innovative formulations. With a total of 2 patents, Goodman has focused on developing topical compositions that enhance the therapeutic effectiveness of retinoic acid while minimizing skin irritation.

Latest Patents

Goodman's latest patents include novel retinoic acid-containing compositions. These compositions are designed in the form of creams, lotions, gels, and similar products. The first patent describes a urethane compound with a molecular weight of up to about 200,000. This compound is created by reacting approximately two moles of a hydroxy-terminated linear alkylene or polyalkylene glycol with one mole of a monomeric organic diisocyanate. The innovative aspect of this formulation is that it decreases percutaneous transmission of retinoic acid, leading to reduced skin irritation while maintaining its therapeutic effectiveness. This composition is particularly useful for treating acne vulgaris, photoaging, senile keratosis, hyperpigmentation, and psoriasis.

The second patent also focuses on retinoic acid-containing polyether-polyurethane compositions. Similar to the first, these compositions are presented in various topical forms. The urethane compound in this formulation has a molecular weight of up to about 60,000. The benefits remain consistent, as it reduces skin irritation without compromising the therapeutic effects of retinoic acid. This formulation is also aimed at treating various skin conditions that were previously deemed unsuitable for retinoic acid treatment.

Career Highlights

Harris Goodman is associated with Penederm, Inc., where he continues to innovate in the field of dermatological products. His work has garnered attention for its potential to improve skin health and address various dermatological issues effectively.

Collaborations

Goodman collaborates with John W Quigley, Jr., who is also a key figure in the development of these innovative compositions. Their partnership has contributed to the advancement of effective skin treatments.

Conclusion

Harris Goodman's contributions to dermatological innovations through his patents reflect his commitment to improving skin health. His work continues to pave the way for effective treatments in dermatology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…